If you've recently been diagnosed with fibromyalgia - or if you've been living with pain for years and just got diagnosed and hearing the word “fibromyalgia” for the first time - there is something you should know NOW.
This is not in your head - and it NEVER WAS.
The story of fibromyalgia is, in many ways, the story of what happens when doctors encounter something they don't understand. Not something that doesn't exist - something they didn't study. Something that didn't fit neatly into their training and their studies. And instead of answering to the patients with curiosity and trying to understand why the hell we were in pain, they decided the problem must be with the patient.
Until recently, patients (most of them women) were told their pain was psychological. Stress. Anxiety. More stress. A lot of us still carry the experience of a long diagnosis and being dismissed and not believed. It's time we take the story back, so that next time a doctor tries to dismiss you, you can at least fight back with some info.
The science has moved on! Here's what it currently says.
A Brief History of Being Told You're Fine
Fibromyalgia-like symptoms have appeared in medical literature for centuries. In the early 1900s, the condition was called "fibrositis" - a term coined by the British physician William Gowers in 1904 - implying inflammation of the fibrous tissues. The name was wrong. There was no detectable inflammation. But it was what they had at the moment. A name.
For much of the 20th century, chronic widespread pain in the absence of a clear biological cause was quietly assigned to the psychiatric category. "Hysteria" was the label for those with lots of pain and sleep issues. This meant (in the eyes of everyone) - that the suffering was generated by the mind rather than the body. The person was doing this to themselves. If they only stopped exaggerating and got out of bed.. Right? (not.)
The name "fibromyalgia" was formally introduced in 1976 to replace "fibrositis." The change came partly because research was not finding any actual inflammation in the fibrous tissues as originally thought. Renaming it to fibromyalgia (from the Latin fibra for fiber, Greek myo for muscle, and algos for pain) was an attempt to describe what was actually being observed: widespread pain in the muscles and connective tissue, without a clear inflammatory cause. It was a more honest name. But it didn't resolve the underlying problem, which was that no one yet understood what was actually happening.
Change came in 1990, when the American College of Rheumatology (ACR) published its first formal classification criteria. To qualify for a fibromyalgia diagnosis, a patient needed to have widespread pain lasting at least three months, plus tenderness at 11 or more of 18 specific anatomical points. For the first time, there was a clinical framework. Patients had a diagnosis that was taken seriously enough to be researched.
The 1990 criteria were revised in 2010 and refined again in 2016, moving away from the tender point exam - which turned out to have significant variability depending on who was doing it - toward a symptom-based model using the Widespread Pain Index (WPI) and a Symptom Severity (SS) scale. This shift reflected a growing understanding that fibromyalgia is not primarily a musculoskeletal condition. It is a disorder of the nervous system.
What Fibromyalgia Actually Is: Central Sensitization Syndrome
The current scientific understanding places fibromyalgia within a group of related conditions known as Central Sensitivity Syndromes (CSS).
Central sensitization is the key process. In a typical nervous system, pain signals travel from the body to the brain, are processed, and are then regulated - turned up or down - by inhibitory pathways. In fibromyalgia, this regulatory system stops working properly. The central nervous system becomes hyperexcitable: amplifying signals that would not normally produce pain, and intensifying signals that should produce only mild discomfort.
The result is what researchers call hyperalgesia (an exaggerated response to painful stimuli) and allodynia (pain from things that are not normally painful - light touch, temperature changes, pressure). The volume is turned up, and it cannot easily be turned back down.
Fibromyalgia sits within the CSS umbrella alongside conditions like irritable bowel syndrome (IBS), chronic migraine, temporomandibular disorder (TMD), and interstitial cystitis. These conditions frequently co-occur, which is not coincidence - they share the same underlying mechanism: a dysregulated, hypersensitive central nervous system.
The Biology: What the Research Actually Shows
This is where the "it's all in your head" claim collapses under the evidence.
Neuroimaging. Functional MRI (fMRI) studies have shown that fibromyalgia patients have significantly altered brain activity in response to pain. When exposed to the same pressure or heat that healthy people report as mild discomfort, fibromyalgia patients show increased activation in the brain's "pain matrix" - including the thalamus, insula, and anterior cingulate cortex - at much lower stimulus intensities. The brain is not imagining pain. It is processing real signals through a system that has lost its ability to regulate itself (Gracely et al., Arthritis & Rheumatism, 2002).
Substance P. Substance P is a chemical involved in pain transmission in the nervous system. Studies have found that its levels in the cerebrospinal fluid of fibromyalgia patients are roughly three times higher than in healthy controls (Russell et al., Arthritis & Rheumatism, 1994). Elevated substance P excites neurons, amplifies pain signals, and promotes neuroinflammation - contributing directly to the heightened pain sensitivity that characterizes the condition.
Neuroinflammation. There is growing evidence that fibromyalgia involves the activation of glial cells - the immune cells of the central nervous system. When glial cells are activated, they release inflammatory mediators that increase neuronal excitability, effectively locking the system into a sensitized state. This creates a feedback loop: chronic input leads to glial activation, which sustains sensitization, which generates more input.
HPA Axis Dysregulation. The hypothalamic-pituitary-adrenal (HPA) axis governs the body's stress response, including cortisol regulation. In fibromyalgia patients, the HPA axis frequently shows abnormal patterns - flattened cortisol curves, altered reactivity to stressors, and impaired recovery from physiological challenge. This is not a response to being stressed about pain. It is a measurable dysfunction in a core regulatory system.
Small Fiber Neuropathy. One of the more recent and significant findings in fibromyalgia research is the presence of small fiber neuropathy (SFN) in a substantial portion of patients - some studies estimating up to 60%. Small fibers are the thin nerve fibers found in the skin that transmit pain and temperature signals. When these fibers are damaged or reduced in density, they generate abnormal input from the periphery that may trigger and sustain central sensitization. This finding matters because it introduces a physical, peripheral component to a condition long assumed to be "purely central" - and it challenges the mind-body binary that was used for so long to dismiss these patients.
The Diagnostic Timeline: Why It Takes So Long
Despite all of the above, getting a fibromyalgia diagnosis remains a long and often exhausting process. Data from the Italian Fibromyalgia Registry put the average time from symptom onset to diagnosis at approximately 3.5 years. Other studies, particularly those conducted before the 2010 revised criteria, have cited delays of up to 5-7 years.
The reasons are many.
The most obvious one is that there is no single biomarker for fibromyalgia. No blood test. No imaging finding that appears in every patient. Diagnosis is based on reported symptoms, their duration, and their distribution - which means it depends on a doctor who knows what they are looking for, and who believes what they are hearing.
Fibromyalgia also overlaps with many other conditions. Fatigue, cognitive difficulties ("fibro fog"), sleep disruption, and widespread pain are features shared with hypothyroidism, rheumatoid arthritis, lupus, multiple sclerosis, and others. A typical diagnostic journey involves ruling these out - which means referrals, waiting lists, and repeat appointments before anything is confirmed.
And then there is a lot of skepticism. Despite the ACR criteria existing since 1990, the condition remains underrecognized in many doctor’s offices. Patients report being told their symptoms are "stress-related," or that their blood work is "normal" so they are fine, as if normal blood work means there is nothing wrong. Many are sent home with advice to exercise more, sleep better, and reduce stress. The post-exertional malaise that makes increased exercise genuinely harmful for many fibromyalgia patients is frequently ignored - either because the doctor doesn't know about it, or because they don't believe it.
The Trauma Connection: ACEs, the HPA Axis, and the Nervous System
This is perhaps the most misunderstood piece of the fibromyalgia picture - and the one most vulnerable to misinterpretation.
There is strong evidence linking adverse childhood experiences (ACEs) - physical, sexual, and emotional abuse, neglect, household dysfunction - to the later development of fibromyalgia. People with fibromyalgia consistently report higher rates of ACEs than the general population, and research shows a dose-response relationship: the higher the ACE score, the greater the risk of developing central sensitization syndromes, and the more severe the symptoms tend to be.
This finding is frequently misread as evidence that fibromyalgia is "psychological." It is not.
The mechanism is biological.
Early and sustained trauma - particularly in childhood, when the nervous system is still developing - produces measurable, long-lasting changes to the HPA axis. The system that regulates how we respond to stress becomes chronically dysregulated: hypersensitive in some areas, blunted in others. Over time, this dysregulation shifts the setpoint of the entire central nervous system. The capacity to process and inhibit pain signals is compromised - not as a metaphor, and not because of maladaptive thinking, but because the regulatory infrastructure was shaped under conditions of chronic threat.
Trauma changes the nervous system. That change is physiological and measurable. And it is one of the pathways - not the only one, but a significant one - through which fibromyalgia develops.
This distinction matters enormously for patients. Being told that childhood trauma plays a role in your fibromyalgia is not the same as being told your pain is not real, or that it is your fault, or that it would resolve if you simply addressed the trauma. It means that your nervous system adapted to what it was given. And that those adaptations have physiological consequences that are now being treated as what they are: a medical condition.
What This Means
Fibromyalgia is real. The pain is real. The cognitive symptoms are real. The fatigue is real. The long road to a diagnosis is real - and the harm caused by that delay is real.
The science is not finished. There is still work to be done on biomarkers, on the relationship between small fiber neuropathy and central sensitization, on the precise mechanisms by which early trauma alters pain processing, and on what effective treatment looks like at the individual level.
But the question of whether this condition exists - whether it is a biological reality or a product of psychological distress - has been answered.
It was answered by fMRI scans showing hyperactivated pain networks. By cerebrospinal fluid samples with three times the expected concentration of substance P. By skin biopsies revealing damaged nerve fibers. By decades of research into a system - the central nervous system - that was behaving in measurable, reproducible, documented ways.
The condition was always real. The medicine just needed time to catch up.